As a key player in Epilepsy, SynapCell will participate to the Anti-Epileptic Drugs and Device Trials XI, taking place in Miami, Florida.
Take a moment to have a one-to-one discussion with Corinne Roucard, founder and CEO of SynapCell and learn more on our capabilitries to secure your epilepsy programs with reliable, objective and clinically-relevant biomarkers of focal and generalized epilepsies using machine-learning-empowered EEG methods.

Looking forward to meeting you there, Save the date!

Secure a private discussion now: hello@synapcell.fr